Marshall Wace North America L.P. Makes New Investment in Welltower Inc (NYSE:WELL)

Marshall Wace North America L.P. purchased a new position in shares of Welltower Inc (NYSE:WELL) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 7,123 shares of the real estate investment trust’s stock, valued at approximately $552,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. raised its holdings in shares of Welltower by 3.7% in the 1st quarter. BlackRock Inc. now owns 39,917,986 shares of the real estate investment trust’s stock valued at $3,097,636,000 after purchasing an additional 1,414,802 shares in the last quarter. Cohen & Steers Inc. boosted its holdings in Welltower by 9.6% during the fourth quarter. Cohen & Steers Inc. now owns 24,865,579 shares of the real estate investment trust’s stock worth $1,725,920,000 after buying an additional 2,173,416 shares in the last quarter. FMR LLC boosted its holdings in Welltower by 19.2% during the fourth quarter. FMR LLC now owns 8,775,971 shares of the real estate investment trust’s stock worth $609,140,000 after buying an additional 1,416,074 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Welltower by 13.4% in the first quarter. Principal Financial Group Inc. now owns 8,719,318 shares of the real estate investment trust’s stock valued at $676,620,000 after purchasing an additional 1,032,562 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of Welltower by 6.6% in the first quarter. Daiwa Securities Group Inc. now owns 7,184,481 shares of the real estate investment trust’s stock valued at $557,516,000 after purchasing an additional 446,202 shares in the last quarter. Institutional investors and hedge funds own 86.98% of the company’s stock.

In other Welltower news, CEO Thomas J. Derosa sold 19,307 shares of the business’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $77.90, for a total value of $1,504,015.30. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.15% of the stock is owned by insiders.

WELL traded up $0.35 during trading hours on Thursday, reaching $84.85. The company’s stock had a trading volume of 1,201,500 shares, compared to its average volume of 2,117,289. The company’s 50-day simple moving average is $83.20. The firm has a market cap of $34.22 billion, a price-to-earnings ratio of 21.05, a PEG ratio of 4.17 and a beta of 0.29. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.79. Welltower Inc has a 52 week low of $60.74 and a 52 week high of $86.91.

Welltower (NYSE:WELL) last posted its earnings results on Tuesday, April 30th. The real estate investment trust reported $1.02 EPS for the quarter, meeting the consensus estimate of $1.02. The firm had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.24 billion. Welltower had a return on equity of 4.97% and a net margin of 13.06%. The business’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period last year, the company earned $0.99 earnings per share. Analysts predict that Welltower Inc will post 4.19 EPS for the current year.

A number of equities analysts have recently weighed in on the stock. BMO Capital Markets cut their price objective on shares of AKITA Drilling from C$5.00 to C$3.50 in a research report on Tuesday, May 7th. Raymond James started coverage on shares of Adverum Biotechnologies in a research note on Thursday, June 13th. They issued a “market perform” rating for the company. Morgan Stanley set a $111.00 target price on shares of Procter & Gamble and gave the stock a “buy” rating in a report on Thursday, March 28th. Deutsche Bank increased their price objective on shares of Welltower from $61.00 to $71.00 and gave the stock a “hold” rating in a report on Friday, March 29th. Finally, Scotiabank set a $80.00 target price on shares of Welltower and gave the company a “hold” rating in a research note on Friday, June 14th. Seven investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $74.79.

About Welltower

Welltower Inc (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

See Also: Front-End Load

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.